Summary
We analysed long-term follow-up results of 175 patients with malignant glioma (110 glioblastoma and 65 anaplastic astrocytoma) treated under five different regimes during the past two decades. The factors of age (less than 40), histology (anaplastic astrocytoma) and type of adjuvant therapy (radiation and chemotherapy) contributed to long survival. The other important factor was the response to adjuvant therapy.
Cases of gross total removal or complete response (CR) of a residual tumour to an adjuvant therapy showed a better prognosis. The three and five year survival rate was 42% and 24%, respectively. The highest CR ratio (23%) was seen in patients treated by intravenous injection of interferon and ACNU in addition to radiotherapy (IAR therapy).
Similar content being viewed by others
References
Akslen LA, Mork SJ, Larsen JL Myrseth E (1988) Giant cell glioblastoma: a work-up of 2 cases with long survival. Acta Neurol Scan 79: 194–199
Ammirati M, Vick N, Liao Y, Ciric I, Mikhael M (1987) Effect of extent of surgical resection on survival and quality of life in patients with supratentorial glioblastoma and anaplastic astrocytomas. Neurosurgery 21: 201–206
Burger PC, Green SB (1987) Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617–1625
Gresser I, Maury C, Brouthy-boye' D (1972) Mechanism of the antitumor effect of interferon in mice. Nature 239: 167–168
Kent DL, Larson EB (1988) Magnetic resonance imaging of the brain and spine is clinical efficacy established after the first decade. Ann Intern Med 107: 402–424
Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T, Yagi K (1990) Growth inhibition of glioma cells transfected with human β-interferon gene by liposomes coupled with a monoclonal antibody. Cacer Res 50: 7826–7829
Nagai M, Asai T (1984) Clinical effect of interferon in malignant brain tumors. Neurosurg Rev 7: 55–64
Ruts HP, De Tribolet N, Calmes JM, Chapuis G (1991) Longtime survival of a patient with glioblastoma and Turcot's syndrome. J Neurosurg 74: 813–815
Shapiro WR, Green SB, Burger PC, Mahaley S, Selker RG, Vangilder JC, Robertson JT, Ransohof J, Mealey J, Strike TA, Pistenmaa DA (1989) Randomized trial of three chemotherapy regimens and two radiotherapy regimens in post operative treatment of malignant glioma. Brain tumor Coop Group Trial 8001. J Neurosurg 191: 1–9
Takakura S, Abe H, Kitamura K, Kitamura K, Miwa T, Takenchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K (1986) Effect of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57
Takeuchi K, Hoshino K (1977) Statistical analysis of factors affecting survival after glioblastoma multiforme. Acta Neurochir (Wien) 37: 57–73
Tashiro T, Yoshida J, Mizuno M, Sugita K (1993) Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumour necrosis factor-α gene. J Neurosurg 78: 252–256
Yamamoto SH, Tanaka H, Kanamori M, Nobuhara M, Namba M (1983) In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa). Cancer 20: 131–138
Yoshida J, Kato K, Wakabayashi T, Enomoto H, Inoue I, Kageyama N (1986) Antitumor activity of interferon-β against malignant glioma in combination with chemotherapeutic agent of nitrosoureas (ACNU). In: Cantell Ket al (eds) The biology of the interferon system 1986. Martinus Nyhoff Netherlands, pp 399–406
Yoshida J, Yamamoto R, Wakabayashi T, Nagata M, Seo H (1990) Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma. J Neurooncol 8: 23–31
Yoshida J, Mizuno M, Yagi K (1991) Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene. J Clin Biochem Nutr 11: 123–128
Yoshida J, Mizuno M, Yagi K (1992) Cytotoxicity of human β-interferon produced in human glioma cells transfected with its gene by means of liposomes. Biochem Inten 28: 1055–1061
Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brook WH, Hunt WE, Maccarty CS, Mahalry MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA (1980) Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1223–1329
Weir B (1973) The relative significance of factors affecting postoperative survival in astrocytomas, grade 3 and 4. J Neurosurg 38: 448–452
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, J., Kajita, Y., Wakabayashi, T. et al. Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta neurochir 127, 55–59 (1994). https://doi.org/10.1007/BF01808547
Issue Date:
DOI: https://doi.org/10.1007/BF01808547